You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hem/ Onc

Showing 1 - 25 of 253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Port Saint Lucie (RGT-419B, RGT-419B in combination with hormonal therapy)

Recruiting
  • Breast Cancer
  • RGT-419B
  • RGT-419B in combination with hormonal therapy
  • Port Saint Lucie, Florida
    Hem-Onc Associates of the Treasure Coast
Apr 18, 2022

Paroxysmal Hemoglobinuria, Nocturnal Trial in Worldwide (Crovalimab, Placebo)

Active, not recruiting
  • Paroxysmal Hemoglobinuria, Nocturnal
  • Paris, France
  • +18 more
Dec 5, 2022

Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

Recruiting
  • Advanced Solid Tumors
  • +6 more
  • Fruquintinib (HMPL-013)
  • Phoenix, Arizona
  • +8 more
Aug 30, 2021

Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

Terminated
Has Results
  • Advanced Solid Tumors
  • Los Angeles, California
  • +29 more
May 21, 2022

Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma Trial in Spain, United States (APX005M, Nivolumab)

Completed
  • Cancer
  • +4 more
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

Completed
Has Results
  • Gastric Cancer
  • Los Angeles, California
  • +33 more
Feb 18, 2022

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

Terminated
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +25 more
Oct 21, 2021

Breast Cancer Trial in United States (Poziotinib)

Completed
Has Results
  • Breast Cancer
  • Huntsville, Alabama
  • +34 more
Feb 28, 2022

NSCLC Trial in Worldwide (Alectinib, Crizotinib)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Phoenix, Arizona
  • +125 more
Dec 2, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Dexamethasone, Prednisone)

Unknown status
  • Multiple Myeloma
  • Encinitas, California
  • +6 more
Aug 12, 2020

Breast Cancer Trial in United States (Ribociclib, Adjuvant endocrine therapy, Placebo)

Completed
Has Results
  • Breast Cancer
  • Tucson, Arizona
  • +32 more
Oct 7, 2021

Non Small Cell Lung Cancer (NSCLC) Trial in Canada, United States (Nivolumab)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Mobile, Alabama
  • +133 more
Jan 25, 2022

Lymphoma Trial in Germany, Poland, United States (Atezolizumab [TECENTRIQ], Obinutuzumab, Polatuzumab Vedotin)

Completed
Has Results
  • Lymphoma
  • Atezolizumab [TECENTRIQ]
  • +3 more
  • Los Angeles, California
  • +18 more
Nov 30, 2020

NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Matching Placebo)

Recruiting
  • Non-Small Cell Lung Cancer
  • Littleton, Colorado
  • +175 more
Jan 12, 2023

Follicular Lymphoma Trial in Worldwide (HCD122)

Completed
  • Follicular Lymphoma
  • Boston, Massachusetts
  • +11 more
Dec 6, 2020

Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

Completed
Has Results
  • Cutaneous T-Cell Lymphoma
  • Birmingham, Alabama
  • +72 more
Jul 22, 2022

Classical Hodgkin's Lymphoma Trial in Worldwide (Panobinostat)

Completed
Has Results
  • Classical Hodgkin's Lymphoma
  • Duarte, California
  • +45 more
Jul 26, 2021

Solid Tumor and Hematologic Malignancies Trial in United States (MEK162)

Completed
Has Results
  • Solid Tumor and Hematologic Malignancies
  • Mobile, Alabama
  • +67 more
Feb 2, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,

Recruiting
  • Metastatic Cancer
  • +2 more
  • Madison, Wisconsin
    UW Carbone Cancer Center
Oct 10, 2023

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (TKI258)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +29 more
Dec 11, 2020